Target intelligence / Profile preview

Microbial cell surface protein and membrane lipid

Molecular classification
Lipid, Protein, Carbohydrate, Glycoprotein
01

Overview

Microbial cell surface proteins and membrane lipids constitute the essential structural and functional boundary of bacteria and fungi, serving as the primary interface with the host environment (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). These components include a diverse array of molecules such as peptidoglycan, lipopolysaccharides (LPS) in Gram-negative bacteria, and ergosterol in fungal membranes (Mesa-Arango et al., 2012, Front Microbiol). They are critical for maintaining osmotic pressure, facilitating nutrient transport, and mediating adhesion to host cells, which is a prerequisite for colonization and infection (Vollmer et al., 2008, FEMS Microbiol Rev). Because many of these structures are absent or significantly different in mammalian cells, they represent high-value targets for selective antimicrobial therapy. For instance, polymyxins target the LPS of Gram-negative bacteria, while daptomycin interacts with membrane phospholipids to cause rapid depolarization (Humphries et al., 2013, Clin Infect Dis). However, the therapeutic utility of targeting these structures is often challenged by the rapid evolution of resistance mechanisms, such as surface charge modification or the production of protective biofilms (Munita & Arias, 2016, Microbiol Spectr). Additionally, some agents targeting microbial lipids can exhibit toxicity due to limited selectivity against host cell membranes, necessitating careful clinical management (Trimble et al., 2016, Cold Spring Harb Perspect Med).

Other names
Microbial cell envelopeBacterial cell wall and membraneFungal cell wall and membraneSurface antigen
02

Mechanism of action

Disruption of membrane integrity, inhibition of cell wall biosynthesis, and interference with surface protein function.

03

Biological functions

Structural integrityCell adhesionMolecular transportSignal transductionImmune evasion
04

Disease associations

InfectionSepsisBacteremiaMycosis
05

Safety considerations

NephrotoxicityNeurotoxicityDisruption of the human microbiomeRapid emergence of antimicrobial resistance
06

Interacting drugs

Polymyxin B

6 more in the full profile.

07

Biomarkers

Lipopolysaccharide (LPS) levelGalactomannan1,3-beta-D-glucanProcalcitonin

Beyond the preview

Go deeper on Microbial cell surface protein and membrane lipid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell surface protein and membrane lipid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call